Erythromelagia: a rare and hard-to-treat condition: a 9-year-old boy responsive to intravenous lidocaine and oral mexilitene

Pain Med. 2013 Feb;14(2):311-2. doi: 10.1111/pme.12030. Epub 2013 Jan 31.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Intravenous
  • Administration, Oral
  • Child
  • Erythromelalgia / drug therapy*
  • Humans
  • Lidocaine / therapeutic use*
  • Male
  • Mexiletine / therapeutic use*
  • Voltage-Gated Sodium Channel Blockers / therapeutic use*

Substances

  • Voltage-Gated Sodium Channel Blockers
  • Mexiletine
  • Lidocaine